Status and phase
Conditions
Treatments
Study type
Funder types
Identifiers
About
This is a phase II study to test adenosine efficacy for down-regulation of the overwhelming inflammation of COVID-19 in the lungs as reflected by clinical recovery of lung function; resolution of clinically relevant markers of lung function, and resolution of systemic markers of inflammation and coagulation.
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
0 participants in 1 patient group
Loading...
Central trial contact
Amy Gunnett
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal